文献速递老年慢病共病管理多重用药

对乙酰氨基酚安全性:养老院居民死亡与心血管事件风险的前瞻性研究

Acetaminophen Safety: Risk of Mortality and Cardiovascular Events in Nursing Home Residents, a Prospective Study.
PubMed 文献 · J Am Geriatr Soc · 2019-03-26

该研究基于法国西南部175家养老院5429名居民(平均86.1岁)的前瞻性数据,分析对乙酰氨基酚使用与18个月随访期内死亡、心肌梗死及卒中风险的关系。结果显示对乙酰氨基酚总体安全,未发现与死亡或心肌梗死风险相关,但在一模型中糖尿病患者卒中风险显著增加(OR=3.19)。

要点

  • 养老院居民中对乙酰氨基酚平均日剂量2352mg,与死亡风险无关(HR=0.97)。
  • 未发现对乙酰氨基酚与心肌梗死风险相关。
  • 一模型中糖尿病患者使用对乙酰氨基酚卒中风险增加(OR=3.19),需更多研究。

核心结论

  • 尽管高龄、多重用药和多重共病,对乙酰氨基酚对养老院研究人群中的大多数人安全,但并非所有人。
  • 对乙酰氨基酚仍是养老院疼痛管理的一线镇痛良好选择。
  • 需要对老年糖尿病患者进行更多研究。

研究设计与样本

  • 前瞻性研究,使用IQUARE项目数据,该项目的设计为多中心、个体化定制、非随机对照试验。
  • 样本来自法国西南部175家养老院,共5429名参与者,平均年龄86.1±8.1岁,73.9%为女性。
  • 基线处方由药师分析对乙酰氨基酚使用情况,18个月随访时从医疗记录获取心肌梗死和卒中报告及死亡日期。
  • 分析在全人群及倾向评分匹配人群中进行,每个结局运行六个模型。

主要发现

  • 2239名参与者服用对乙酰氨基酚,平均日剂量2352±993 mg。
  • 死亡风险:HR=0.97(95%CI 0.86-1.10)。
  • 未发现对乙酰氨基酚摄入与死亡或心肌梗死风险之间的关联。

关键数值与推荐

  • 对乙酰氨基酚平均日剂量2352±993 mg(服用者中)。
  • 死亡风险HR=0.97(95%CI 0.86-1.10)。

临床怎么用

  • 对乙酰氨基酚可作为养老院老年居民的一线镇痛选择,但需关注糖尿病患者卒中风险。
  • 处方对乙酰氨基酚时应评估患者糖尿病状态及卒中风险。

局限性

  • 研究为非随机对照设计,可能受混杂因素影响。
  • 卒中风险仅在部分模型和糖尿病亚组中显著,需进一步验证。
  • 依赖养老院工作人员通过在线问卷收集数据,可能存在报告偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acetaminophen is the most widely used analgesic today. A recent systematic review found increased adverse events and mortality at therapeutic dosage. Our aim was to challenge these results in a large sample of older adults living in nursing homes (NHs). DESIGN: Prospective study using data from the Impact of Educational and Professional Supportive Interventions on Nursing Home Quality Indicators project (IQUARE), a multicenter, individually tailored, nonrandomized controlled trial in NHs across southwestern France. SETTING/PARTICIPANTS: We studied data from 5429 participants living in 175 NHs (average age, 86.1 ± 8.1 years; 73.9% women). MEASUREMENTS: All prescriptions obtained at baseline were analyzed by a pharmacist for acetaminophen use as stand-alone or associated. Myocardial infarction (MI) and strokes were reported from participants' medical records at 18-month follow-up. Dates of death were obtained. Data collection was done through an online questionnaire at baseline and at 18 months by NH staff. Analyses were realized in our total population and a population matched on propensity score of acetaminophen intake. Six models were run for each outcome. RESULTS: A total of 2239 participants were taking, on average, 2352 ± 993 mg of acetaminophen daily. Results for mortality were: hazard ratio (HR) = 0.97 (95% confidence interval [CI] = 0.86-1.10). No associations between acetaminophen intake and the risk of mortality or MI were found. In one of our models, acetaminophen intake was associated with a significant increased risk of stroke in diabetic subjects (OR = 3.19; 95% CI = 1.25-8.18; P = .0157). [Correction added March 16, 2019, after first publication online. In the previous sentence, "HR" was mistakenly used instead of "OR".] CONCLUSION: Despite old age, polypharmacy, and polymorbidity, acetaminophen was found safe for most, but not all, of our NH study population. Pain management in NHs is a health priority, and acetaminophen remains a good therapeutic choice as a first-line analgesic. More studies are needed on older diabetic patients.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Girard P, Sourdet S, Cantet C, et al. Acetaminophen Safety: Risk of Mortality and Cardiovascular Events in Nursing Home Residents, a Prospective Study. J Am Geriatr Soc. 2019. PMID: 30912588. doi:10.1111/jgs.15861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。